• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
PVP-K30-----pharma excipients(CAS No.9003-39-8)
Tobramycin
Povidone iodine 20% powder
Povidone iodine 10% powder
SULBACTAM SODIUM STERILE
Food Additives Bulk Sucralose Neotame Advantame Powder

Troikaa bags recognition from Govt of India

expressbpdMarch 02, 2018

Tag: Troikaa , India Pharma Innovation of The Year Award , India

Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals, Government of India, recently conferred India Pharma Innovation of The Year Award to Troikaa Pharmaceuticals. The award was given in recognition to company’s achievement towards patented innovation in the field of novel drugs delivery systems.

On behalf of Troikaa Pharma, the award was received by Dr Ketan R Patel, CMD, by the hands of Ananth Kumar, Minister (Chemicals & Fertilizers), Government of India, during the Inaugural Session of India Pharma Exhibition 2018, held in Bengaluru.

Register as Visitor to CPhI China 2018!

Previous:Torrent shareholders clear hike in borrowing limit to Rs 15k cr

Next:Pfizer to include ceratin brands for consumer health biz

Related News

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

Troikaa bags recognition from Govt of India | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Mifepristone (INDIA DMF)

Mifepristone (INDIA DMF)
Indian Trum etflower Seed Extract

Indian Trum etflower Seed Extract

Top Quality Indian Bread P.E.

Top Quality Indian Bread P.E.
100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder

100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder
Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract

Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract
Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service